Zimmer Biomet : Description Reconciliation of Gross Profit & Margin to Adjusted Gross Profit & Margin
February 04, 2020 at 05:29 pm IST
Share
ZIMMER BIOMET HOLDINGS, INC.
Reconciliation of Gross Profit & Margin to Adjusted Gross Profit & Margin
For the Quarterly and Year-to-Date Periods in Calendar Year Ending December 31, 2019
(in millions, unaudited)
Three Months Ended
Three Months Ended
Three Months Ended
Three Months Ended
Year Ended
March 31, 2019
June 30, 2019
September 30, 2019
December 31, 2019
December 31, 2019
Net Sales
$
1,975.5
$
1,988.6
$
1,892.4
$
2,125.7
$
7,982.2
Cost of products sold, excluding intangible asset amortization
553.4
581.3
535.7
582.2
2,252.6
Intangible asset amortization
143.4
146.9
146.6
147.4
584.3
Gross profit
$
1,278.7
$
1,260.4
$
1,210.1
$
1,396.1
$
5,145.3
Inventory and manufacturing-related charges
2.0
34.1
11.6
6.2
53.9
Quality remediation
-
0.7
0.8
3.7
5.2
Intangible asset amortization
143.4
146.9
146.6
147.4
584.3
Adjusted gross profit
$
1,424.1
$
1,442.1
$
1,369.1
$
1,553.4
$
5,788.7
Gross margin
64.7
%
63.4
%
63.9
%
65.7
%
64.5
%
Inventory and manufacturing-related charges
0.1
1.7
0.6
0.3
0.7
Quality remediation
-
-
-
0.2
-
Intangible asset amortization
7.3
7.4
7.9
6.9
7.3
Adjusted gross margin
72.1
%
72.5
%
72.4
%
73.1
%
72.5
%
ZIMMER BIOMET HOLDINGS, INC.
Reconciliation of Gross Profit & Margin to Adjusted Gross Profit & Margin
For the Quarterly and Year-to-Date Periods in Calendar Year Ending December 31, 2018
(in millions, unaudited)
Three Months Ended
Three Months Ended
Three Months Ended
Three Months Ended
Year Ended
March 31, 2018
June 30, 2018
September 30, 2018
December 31, 2018
December 31, 2018
Net Sales
$
2,017.6
$
2,007.6
$
1,836.7
$
2,071.0
$
7,932.9
Cost of products sold, excluding intangible asset amortization
575.8
583.7
529.0
583.4
2,271.9
Intangible asset amortization
150.8
149.5
147.6
148.0
595.9
Gross profit
$
1,291.0
$
1,274.4
$
1,160.1
$
1,339.6
$
5,065.1
Inventory and manufacturing-related charges
7.2
12.5
5.0
7.8
32.5
Quality remediation
3.6
7.9
2.0
5.0
18.5
Intangible asset amortization
150.8
149.5
147.6
148.0
595.9
Adjusted gross profit
$
1,452.6
$
1,444.3
$
1,314.7
$
1,500.4
$
5,712.0
Gross margin
64.0
%
63.5
%
63.2
%
64.7
%
63.9
%
Inventory and manufacturing-related charges
0.4
0.6
0.3
0.4
0.4
Quality remediation
0.1
0.4
0.1
0.2
0.2
Intangible asset amortization
7.5
7.4
8.0
7.1
7.5
Adjusted gross margin
72.0
%
71.9
%
71.6
%
72.4
%
72.0
%
Attachments
Original document
Permalink
Disclaimer
Zimmer Biomet Holdings Inc. published this content on 04 February 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 February 2020 11:58:01 UTC
Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows:
- reconstruction implants (57.5%): knees replacement (58.8% of net sales), hips replacement (41.2%);
- surgical products and traumatology equipment (22.1%);
- dental, spinal and craniomaxillofacial implants (12.8%);
- other (7.6%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation.
At the end of 2021, the group had approximately 30 production sites worldwide.
Net sales are distributed geographically as follows: Americas (61.3%), Europe/Middle East/Africa (21.3%) and Asia/Pacific (17.4%).
ZIMMER BIOMET HOLDINGS, INC. 
